Pfizer reported encouraging Phase 2 results for tilrekimig, a trispecific antibody for moderate to severe atopic dermatitis. The drug improved EASI-75 response rates and showed strong efficacy with monthly dosing.
Merck and Cyto-Facto sign an MoU to accelerate cell and gene therapy manufacturing in APAC, focusing on Japan and India, with a goal to improve patient access to therapies.
India’s rare disease ecosystem took centre stage at the Rare Diseases Action Summit 2026 in New Delhi, organised by the IHW Council, bringing together policymakers, healthcare leaders, patient advocates, industry experts and researchers to discuss so
Aurobindo Pharma said its Unit IV facility operated by APL Healthcare has received a Voluntary Action Indicated (VAI) classification from the U.S. Food and Drug Administration following a recent inspection, indicating minor observations with no regul
India’s drug regulator has barred pharmaceutical companies from promoting weight-loss drugs, warning against direct and surrogate advertising.
Agilent signs $950 million deal to acquire Biocare Medical, enhancing its cancer diagnostics and pathology portfolio with innovative IHC and molecular pathology solutions.
Abbott introduces XIENCE Skypoint in India, an advanced stent for treating complex heart blockages. It offers greater flexibility, precision, and improved treatment options for patients.
Mankind Pharma and health experts emphasize early screening for chronic kidney disease (CKD) on World Kidney Day, urging proactive kidney health and regular check-ups to prevent progression.
The Ministry of Health and Family Welfare (MoHFW) has published a draft Gazette notification proposing an amendment to the Drugs Rules, 1945, to make changes to the requirements of testing of blood products.
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has urged Indian pharmaceutical exporters to diversify shipping routes and explore alternative logistics options as tensions in the Gulf region threaten key global trade corrid...